Effects of Sour Tea (Hibiscus Sabdariffa L.) Consumption on Anthropometric Indices: A Systematic Review and Meta-Analysis

  • Somayeh Saboori* Department of Nutrition, School of Health and Nutrition Nutritional Health Research Center Lorestan University of Medical Sciences
  • Salman Mohammadi
  • Mahboobe Hosseinikia
  • Naseh Pahlavani
  • Ali Ghaffarian-Bahraman
  • Esmaeil Yousefi Rad*
Keywords: Sour tea, Body weight, Body composition, Anthropometric Indices, Meta-analysis


Beverages of Hibiscus Sabdariffa L. (sour tea) are widely used for improving liver diseases, hypertension cardio-metabolic indices, and body composition. Nevertheless, little is known about the impacts of sour tea on body composition and anthropometric indices. This study aimed to systematically review and perform a meta-analysis on the evidence evaluating the effects of sour tea on body composition and anthropometric indices. International databases, including PubMed, Scopus, and Web of Science, were searched to find clinical trial studies published up to February 2022. The response variables examined in the present study included body weight, body mass index, waist circumference, body fat mass, and hip circumference. Pooled effect size of mean difference (95% CI) between the treatment and placebo interventions was estimated for body weight (-0.51 kg, -3.35, 2.32), body mass index (-0.09 kg/m2, -0.98, 0.80), waist circumference (-0.26 cm, -2.86, 2.35), hip circumference (-0.07 cm, -2.87, 2.74), and body fat mass (-1.85 %, -4.90, 1.19). This meta-analysis showed that despite the reducing effect of sour tea consumption on body composition and anthropometric indices, this effect was not statistically significant. However, there are several determinant factors that probably affected our findings, including the type, dosage, and duration of the intervention as well as the heterogeneity of the target population. Thus, future well‑designed clinical trials are suggested to establish a definitive conclusion in this regard.


Ayatollahi S, Ghoreshizadeh Z. Prevalence of obesity and overweight among adults in Iran. Obesity reviews. 2010;11(5):335-7.

Janghorbani M, Amini M, Willett WC, Gouya MM, Delavari A, Alikhani S, et al. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity. 2007;15(11):2797-808.

Mohammadi S, Rastmanesh R, Jahangir F, Amiri Z, Djafarian K, Mohsenpour MA, et al. Melatonin supplementation and anthropometric indices: A randomized double-blind controlled clinical trial. BioMed Research International. 2021;2021.

Kumar S, Kelly AS, editors. Review of childhood obesity: from epidemiology, etiology, and comorbidities to clinical assessment and treatment. Mayo Clinic Proceedings; 2017: Elsevier.

Saboori S, Rad EY, Mardani M, Khosroshahi MZ, Nouri Y, Falahi E. Effect of Q10 supplementation on body weight and body mass index: A systematic review and meta-analysis of randomized controlled clinical trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(2):1179-85.

Tong TJ, Mohammadnezhad M, Alqahtani NS. Determinants of overweight and obesity and preventive strategies in Pacific countries: a systematic review. Global Health Journal. 2022.

Katz DL, O'Connell M, Njike VY, Yeh M-C, Nawaz H. Strategies for the prevention and control of obesity in the school setting: systematic review and meta-analysis. International journal of obesity. 2008;32(12):1780-9.

Kidambi S, Batsis JA, Donahoo WT, Jastreboff AM, Kahan S, Saunders KH, et al. Dietary supplements and alternative therapies for obesity: A Perspective from The Obesity Society’s Clinical Committee. Obesity. 2021;29(7):1095-8.

Haghani F, Arabnezhad M-R, Mohammadi S, Ghaffarian-Bahraman A. Aloe vera and Streptozotocin-Induced Diabetes Mellitus. Revista Brasileira de Farmacognosia. 2022:1-14.

Chang H-C, Peng C-H, Yeh D-M, Kao E-S, Wang C-J. Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food & function. 2014;5(4):734-9.

Herrera-Arellano A, Flores-Romero S, Chavez-Soto M, Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine. 2004;11(5):375-82.

Mozaffari-Khosravi H, Jalali-Khanabadi B, Afkhami-Ardekani M, Fatehi F, Noori-Shadkam M. The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes. Journal of human hypertension. 2009;23(1):48-54.

Aurelio DL, Edgardo RG, Navarro‐Galindo S. Thermal kinetic degradation of anthocyanins in a roselle (Hibiscus sabdariffa L. cv.‘Criollo’) infusion. International journal of food science & technology. 2008;43(2):322-5.

Serban C, Sahebkar A, Ursoniu S, Andrica F, Banach M. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials. Journal of hypertension. 2015;33(6):1119-27.

Pérez-Torres I, Ruiz-Ramírez A, Baños G, El-Hafidi M. Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome. Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Cardiovascular & Hematological Agents). 2013;11(1):25-37.

Liu Ks, Tsao Sm, Yin Mc. In vitro antibacterial activity of roselle calyx and protocatechuic acid. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2005;19(11):942-5.

Najafpour Boushehri S, Karimbeiki R, Ghasempour S, Ghalishourani SS, Pourmasoumi M, Hadi A, et al. The efficacy of sour tea (Hibiscus sabdariffa L.) on selected cardiovascular disease risk factors: A systematic review and meta‐analysis of randomized clinical trials. Phytotherapy Research. 2020;34(2):329-39.

Lin H-H, Chen J-H, Wang C-J. Chemopreventive properties and molecular mechanisms of the bioactive compounds in Hibiscus sabdariffa Linne. Current medicinal chemistry. 2011;18(8):1245-54.

Ali BH, Wabel NA, Blunden G. Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: a review. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2005;19(5):369-75.

Tsai P-J, McIntosh J, Pearce P, Camden B, Jordan BR. Anthocyanin and antioxidant capacity in Roselle (Hibiscus sabdariffa L.) extract. Food research international. 2002;35(4):351-6.

Bule M, Albelbeisi AH, Nikfar S, Amini M, Abdollahi M. The antidiabetic and antilipidemic effects of Hibiscus sabdariffa: A systematic review and meta-analysis of randomized clinical trials. Food Research International. 2020;130:108980.

Aziz Z, Wong SY, Chong NJ. Effects of Hibiscus sabdariffa L. on serum lipids: A systematic review and meta-analysis. Journal of ethnopharmacology. 2013;150(2):442-50.

Ellis LR, Zulfiqar S, Holmes M, Marshall L, Dye L, Boesch C. A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers. Nutrition reviews. 2021.

Zhang B, Yue R, Wang Y, Wang L, Chin J, Huang X, et al. Effect of Hibiscus sabdariffa (Roselle) supplementation in regulating blood lipids among patients with metabolic syndrome and related disorders: A systematic review and meta‐analysis. Phytotherapy Research. 2020;34(5):1083-95.

Shafiee M, Mohammadi V, Kazemi A, Davarpanah H, Tabibzadeh SM, Babajafari S, et al. The effect of Hibiscus sabdariffa (sour tea) compared to other herbal teas and antihypertension drugs on cardiometabolic risk factors: Result from a systematic review and meta-analysis. Journal of Herbal Medicine. 2021;29:100471.

Abdelmonem M, Ebada MA, Diab S, Ahmed MM, Zaazouee MS, Essa TM, et al. Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis of Published Randomized Controlled Trials. Journal of Cardiovascular Pharmacology. 2022;79(1):e64-e74.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372.

Higgins JP. green S. Cochrane handbook for systematic reviews of interventions version. 2011;5(0):3.

Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343.

Asgary S, Soltani R, Zolghadr M, Keshvari M, Sarrafzadegan N. Evaluation of the effects of roselle (Hibiscus sabdariffa L.) on oxidative stress and serum levels of lipids, insulin and hs-CRP in adult patients with metabolic syndrome: a double-blind placebo-controlled clinical trial. Journal of Complementary and Integrative Medicine. 2016;13(2):175-80.

Izadi F, Farrokhzad A, Tamizifar B, Tarrahi MJ, Entezari MH. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non‐alcoholic fatty liver disease: A double‐blind randomized controlled clinical trial. Phytotherapy Research. 2021;35(1):477-85.

Kuriyan R, Kumar DR, Kurpad AV. An evaluation of the hypolipidemic effect of an extract of Hibiscus Sabdariffa leaves in hyperlipidemic Indians: a double blind, placebo controlled trial. BMC complementary and alternative medicine. 2010;10(1):1-8.

Sari C, Damayanthi E, Kustiyah L. The effect of rosella beverage intervention on lipid profiles and antropometric in obese adult men. EXECUTIVE EDITOR. 2018;9(12):12654.

Yusni Y, Meutia F. Action mechanism of Rosella (Hibiscus sabdariffa L.) used to treat metabolic syndrome in elderly women. Evidence-Based Complementary and Alternative Medicine. 2020;2020.

Guardiola S, Mach N. Potencial terapéutico del Hibiscus sabdariffa: una revisión de las evidencias científicas. Endocrinología y Nutrición. 2014;61(5):274-95.

Puro K, Sunjukta R, Samir S, Ghatak S, Shakuntala I, Sen A. Medicinal uses of Roselle plant (Hibiscus sabdariffa L.): a mini review. Indian Journal of Hill Farming. 2014;27(1):81-90.

Kuriyan R, Kumar DR, R R, Kurpad AV. An evaluation of the hypolipidemic effect of an extract of Hibiscus Sabdariffa leaves in hyperlipidemic Indians: a double blind, placebo controlled trial. BMC Complement Altern Med. 2010;10:27.

Da-Costa-Rocha I, Bonnlaender B, Sievers H, Pischel I, Heinrich M. Hibiscus sabdariffa L.–A phytochemical and pharmacological review. Food chemistry. 2014;165:424-43.

Jiménez-Ferrer E, Alarcón-Alonso J, Aguilar-Rojas A, Zamilpa A, Tortoriello J, Herrera-Ruiz M. Diuretic effect of compounds from Hibiscus sabdariffa by modulation of the aldosterone activity. Planta medica. 2012;78(18):1893-8.

Kao E-S, Hsu J-D, Wang C-J, Yang S-H, Cheng S-Y, Lee H-J. Polyphenols extracted from Hibiscus sabdariffa L. inhibited lipopolysaccharide-induced inflammation by improving antioxidative conditions and regulating cyclooxygenase-2 expression. Bioscience, biotechnology, and biochemistry. 2009;73(2):385-90.

Peng C-H, Chyau C-C, Chan K-C, Chan T-H, Wang C-J, Huang C-N. Hibiscus sabdariffa polyphenolic extract inhibits hyperglycemia, hyperlipidemia, and glycation-oxidative stress while improving insulin resistance. Journal of agricultural and food chemistry. 2011;59(18):9901-9.

Yang M-Y, Peng C-H, Chan K-C, Yang Y-S, Huang C-N, Wang C-J. The hypolipidemic effect of Hibiscus sabdariffa polyphenols via inhibiting lipogenesis and promoting hepatic lipid clearance. Journal of agricultural and food chemistry. 2010;58(2):850-9.

Stienstra R, Duval C, Keshtkar S, van der Laak J, Kersten S, Muller M. Peroxisome proliferator-activated receptor γ activation promotes infiltration of alternatively activated macrophages into adipose tissue. Journal of Biological Chemistry. 2008;283(33):22620-7.

Zhang W, Sun Q, Zhong W, Sun X, Zhou Z. Hepatic peroxisome proliferator‐activated receptor gamma signaling contributes to alcohol‐induced hepatic steatosis and inflammation in mice. Alcoholism: Clinical and Experimental Research. 2016;40(5):988-99.

Review Article